Abstract: The present invention relates to hair colouring and hair bleaching compositions comprising a first component comprising at least one oxidizing agent and a C6 to C16 alkyl glucoside and a second component comprising an anionic surfactant and a fatty alcohol. The compositions surprisingly provide improved hair colourant and bleaching compositions which deliver lift, lightening and colour, whilst minimizing damage and which provide the required viscosity both pre and post mixing of the first and second components.

Abstract: The invention provides an additive for lowering the minimum usable temperature of a biodiesel fuel or a diesel/biodiesel blend. The additive comprises at least one saccharide ester and a polymer having a comb structure. In some instances there is only one saccharide ester present. In this case the saccharide ester comprises at least one saturated ester group and at least one unsaturated ester group. In other instances, there is more than one saccharide ester is present. In these cases the additive comprises a first saccharide ester comprising at least one saturated ester group and a second saccharide ester comprising at least one unsaturated ester group.

Abstract: The present invention relates to the field of devices which store data for a period of time. In one form, the invention relates to devices which store data in which the data store is subject to periodic and/or relatively short power outages. In one example, the invention relates to a radio frequency identification (“RFID”) transponder, and more particularly to a RFID transponder that is used in orientation independent applications. Other applications of the present invention are to devices used where supply power is intermittent. In a first aspect of embodiments described herein there is provided a.method of and/or device comprising a memory adapted to store data, a supply of power adapted to provide supply power to the memory, a path of leakage, the leakage path serving, over time, to diminish the integrity of data stored in the memory, and a leakage attenuator adapted to selectively attenuate the rate of leakage.

Abstract: Methods and apparatus for compressing data for network transport in support of continuous availability of applications are described. One computer-implemented method of compressing data includes receiving a current instance of data in an input buffer. A candidate chunk of data is selected from the input buffer. A signature hash is computed from a signature length range of data within the candidate chunk. A matching dictionary entry having a matching signature hash from a multi-tiered dictionary is identified. The matching dictionary entry prospectively identifies a location of a prior occurrence of a selected range of consecutive symbols including the signature length range of data within at least one of the current instance of data and a prior instance of data in the input buffer. A dedupe processed representation of the instance of data is formed wherein a dedupe item is substituted for the selected range of consecutive symbols if the selected range is verified as recurring.

Abstract: The present invention relates to hair colouring and hair bleaching compositions comprising a first component comprising at least one oxidizing agent and a C6 to C16 alkyl glucoside and a second component comprising an anionic surfactant and a fatty alcohol. The compositions surprisingly provide improved hair colourant and bleaching compositions which deliver lift, lightening and colour, whilst minimizing damage and which provide the required viscosity both pre and post mixing of the first and second components.

Abstract: The present invention pertains to implantable or insertable medical devices which comprise a substrate and one or more therapeutic-agent-containing regions contain one or more therapeutic agents. In various aspects of the invention, one or more characteristics of such therapeutic-agent-containing regions are controlled. Further aspects of the invention relate to methods of forming such devices and to methods of using such devices.

Abstract: The invention relates to methods for diagnosis of tuberculosis in an animal, the methods comprising determining the presence or absence of, or an immune response to a group of antigens comprising (i) the group consisting of Rv3616 antigen, MPB70 antigen, MPB83 antigen, and ESAT 6 antigen; or (ii) at least seven of the antigens of the group consisting of Rv3616 antigen, MPB70 antigen, MPB83 antigen, ESAT 6 antigen, CFP10 antigen, ? crystalline 2 antigen, PE35 antigen, and PPE68 antigen. Also provided is a method for the diagnosis of the presence of tuberculosis in a reservoir animal e.g. a badger, said method comprising determining the presence or absence of, or an immune response to Rv3616 antigen, MPB70 antigen, and MPB83 antigen. Kits for carrying out the methods are also provided.

Abstract: A drug delivery balloon (10) has a drug thereon in the form of crystalline particles (12), the drug having a predetermined size distribution. Optionally marker particles (14, 16) are also provided. A texturized coating (18), a cap layer (20) and/or other methods may be used to increase particle loading capacity of the balloon.

Abstract: The present invention provides a method that enables the preparation of fully cooked farinaceous products with sensory properties that are comparable to those of fried products, but having a substantially lower fat content than their fried counterparts. More particularly, the invention relates a method of preparing a fully cooked farinaceous food product, said method comprising the successive steps of: preparing a farinaceous dough or batter by mixing flour, water and optionally one or more other bakery ingredients; dividing the dough or batter into one or more portions; and cooking said one or more portions by exposing them (i) for in total 20-600 seconds to infrared radiation, more than 50% of the energy content of said infrared radiation stemming from infrared radiation having a wavelength in the range of 0.7-10 ?m and (ii) for in total 20-600 seconds to impingement with hot air having a temperature of at least 150° C.

Abstract: This invention relates to a composition comprising at least two chemically different fluorophores, providing a donor and an acceptor respectively, connected together by at least one linker moiety and bonded to a binder moiety.

Abstract: The present invention provides an airfoil for a third stage nozzle guide vane having an external surface with first and second sides. The external surface extends spanwise between a hub and a tip and streamwise between a leading edge and a trailing edge of the airfoil. The external surface includes a contour substantially defined by Table 1 as listed in the specification.

Abstract: Visual interaction with an analytics-driven model view composition application. The application includes a data-model binding component that binds input data to model parameters, an analytics solver component that solves for remaining unknown model parameters, and a view composition component that generates a view composition using the model parameters. In one visual interaction, various solutions of the model are provided in alternative views of various view compositions in a single integrated composition. In another interaction, regardless of whether there are multiple view compositions illustrated in a single integrated view, there might be visual prompts in the view composition that suggest an adjustment to make that might move the value of a particular model parameter in a desired direction.

Abstract: Carbon dioxide is separated from a gas stream using a supported carrier liquid membrane having a selected concentration of carrier species, the method being especially suitable for use in anaesthesia under conditions of periodic flow.

Abstract: Certain exemplary embodiments can provide a method that can include: sending software to a first information device and to a second information device, the software adapted to cause display of information regarding user-selected items; receiving an identifier of a selected item; and providing the identifier to the software on the second information device.

Abstract: Certain exemplary embodiments can provide a method that can include: sending software to a first information device and to a second information device, the software adapted to cause display of information regarding user-selected items; and providing content to the software running on the second information device, the software adapted to cause the content to be rendered via the second information device.

Abstract: According to an aspect of the invention, medical devices are provided, which include a nanoparticle-derived inorganic layer disposed over a least a portion of structure that includes a substrate, and optionally, a therapeutic-agent-containing layer disposed over at least a portion of the substrate. In some embodiments, the inorganic layer is a nanoporous inorganic layer. Other aspects of the invention comprise methods for forming such medical device.

Abstract: Methods, systems, and computer program products for processing three-dimensional image data to render an image from a viewpoint within or beyond an occluding region of the image data are disclosed. According to one method, a set of three-dimensional image data is accessed. The image data includes image data for a surface of interest and image data for a region occluding the surface of interest from a desired viewpoint. The viewpoint may be within or beyond the occluding region. A plurality of rays is cast from the viewpoint to the surface. Along each ray, an occlusion determination is made independent from a volume rendering transfer function definition to render voxels within the occluding region as transparent or partially transparent. The volume rendering transfer function is applied along a portion of each ray outside of the occluding region to render voxels defining surface of interest as visible. The voxels that define the surface are displayed as visible.

Abstract: An implantable or insertable medical device is provided which includes as components: (a) a substrate component comprising a depression that is at least partially filled with a therapeutic agent-containing material that comprises a first therapeutic agent, and (b) a particulate composition disposed in the depression such that it regulates transport of chemical species between the depression and the exterior of the device upon implantation or insertion of the device into a subject.

Abstract: An implantable or insertable medical device is provided which includes as components: (a) a substrate component comprising a depression that is at least partially filled with a therapeutic agent-containing material that comprises a first therapeutic agent, and (b) a pre-formed filter insert disposed in the depression such that it regulates transport of chemical species between the depression and the exterior of the device upon implantation or insertion of the device in vivo.